1
|
İpekoğlu G, Apaydın N, Çetin T, Eren AN, Topçu P, Yücelsoy B, Civelek G, Sakar M. Examining the relationship between genetic polymorphisms (BDKRB2, GNB3, HIF1A, MCT1, NOS3) and endurance athlete status. Eur J Appl Physiol 2024; 124:1943-1958. [PMID: 38753016 PMCID: PMC11199302 DOI: 10.1007/s00421-024-05498-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2023] [Accepted: 05/05/2024] [Indexed: 06/27/2024]
Abstract
PURPOSE Genetic factors are important in terms of athletic performance. Recent studies to determine the relationship between the genes that lead to physiological responses have attracted attention. In this respect, this meta-analysis study was designed to examine the relationship between genetic polymorphism (BDKRB2 rs5810761, GNB3 rs5443, HIF1A rs11549565, MCT1 rs1049434, NOS3 rs2070744) and endurance athlete's status. METHODS The search included studies published from 2009 to 2022. To determine the relevant studies, Pubmed, Web of Science databases were systematically scanned. Only case-control studies were included in the meta-analysis. To determine the relevant studies, Pubmed, Web of Science databases were systematically scanned, and a total of 31 studies met the criteria for inclusion in the meta-analysis. Relevant data from the included studies were collected and analyzed using a random effects or fixed effects model. The effect size was calculated as the odds ratio or a risk ratio the corresponding 95% confidence intervals. RESULTS According to the results of the analysis, BDKRB2 rs5810761 + 9 allele, and NOS3 rs2070744 T allele were significantly more prevalent in endurance athletes (p < 0.05). Genotype distributions of BDKRB2 rs5810761, MCT1 rs1049434, and NOS3 rs2070744 showed significant differences in the dominant model (p < 0.05). However, no significant association was found between endurance athlete status and GNB3 rs5443 and HIF1A rs11549465 polymorphisms. CONCLUSION These results show that some gene polymorphisms play an important role in endurance athlete status and suggest that having a specific genetic basis may also confer a physiological advantage for performance.
Collapse
Affiliation(s)
| | | | - Tuğba Çetin
- School of Physical Education and Sports, Karabuk University, Karabuk, Turkey.
| | | | - Pelinsu Topçu
- Faculty of Sport Science, Ordu University, Ordu, Turkey
| | | | | | - Mert Sakar
- Faculty of Sport Science, Ordu University, Ordu, Turkey
| |
Collapse
|
2
|
Putative Role of MCT1 rs1049434 Polymorphism in High-Intensity Endurance Performance: Concept and Basis to Understand Possible Individualization Stimulus. Sports (Basel) 2021; 9:sports9100143. [PMID: 34678924 PMCID: PMC8537363 DOI: 10.3390/sports9100143] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Revised: 10/11/2021] [Accepted: 10/13/2021] [Indexed: 01/09/2023] Open
Abstract
Monocarboxylate transporters (MCTs) have been proposed as important mediators of the exchange between lactate (La−) producer and La− recipient (consumer) cells. Previous studies have suggested that the MCT1 A1470T genotype could be related to different physical performance phenotypes. This study followed the guidelines for Strengthening the Reporting of Genetic Association Studies (STREGA) and aimed to evaluate the distribution of the MCT1 polymorphism rs1049434 in endurance-trained athletes compared to the untrained population. Moreover, this study explored the potential influence of the polymorphism alleles phenotypes on high-intensity exercise performance. In a cross-sectional study fashion, a total of 85 triathletes from northern Spain were genotyped for MCT1 rs1049434 and compared to a control group of 107 healthy male participants (1000 Genomes Research Study for Iberian Populations in Spain). All athletes performed a 30 s Wingate all-out test (WAnT) on a cycle ergometer. Peak and mean power (absolute and relative) were measured. After verification of the Hardy–Weinberg equilibrium, the findings indicated that the MCT1 TT genotype was overrepresented in triathletes in comparison to the genotypic frequency of the general Spanish population. No significant associations were found between any MCT1 genotype and peak or mean power performance in the WAnT. Further studies are required to understand the relationship among MCT1 A1470T polymorphism, endurance-trained athletes, and high-intensity performance.
Collapse
|
3
|
The MCT1 gene Glu490Asp polymorphism (rs1049434) is associated with endurance athlete status, lower blood lactate accumulation and higher maximum oxygen uptake. Biol Sport 2021; 38:465-474. [PMID: 34475628 PMCID: PMC8329966 DOI: 10.5114/biolsport.2021.101638] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 09/14/2020] [Accepted: 10/10/2020] [Indexed: 01/07/2023] Open
Abstract
The purpose of this study was to explore the association of the MCT1 gene Glu490Asp polymorphism (rs1049434) with athletic status and performance of endurance athletes. A total of 1,208 Brazilians (318 endurance athletes and 890 non-athletes) and 867 Europeans (315 endurance athletes and 552 non-athletes) were evaluated in a case-control approach. Brazilian participants were classified based on self-declared ethnicity to test whether the polymorphism was different between Caucasians and Afro-descendants. Moreover, 66 Hungarian athletes underwent an incremental test until exhaustion to assess blood lactate levels, while 46 Russian athletes had their maximum oxygen uptake ( V ⋅ O 2 max ) compared between genotypes. In the Brazilian cohort, the major T-allele was more frequent in Caucasian top-level competitors compared to their counterparts of lower competitive level (P = 0.039), and in Afro-descendant athletes compared to non-athletes (P = 0.015). Similarly, the T-allele was more frequent in European athletes (P = 0.029). Meta-analysis of the Brazilian and European cohorts confirmed that the T-allele is over-represented in endurance athletes (OR: 1.48, P = 0.03), especially when Afro-descendant athletes were included in the meta-analysis (OR: 1.58, P = 0.005). Furthermore, carriers of the T/T genotype accumulated less blood lactate in response to intense effort (P < 0.01) and exhibited higher V ⋅ O 2 max (P = 0.04). In conclusion, the Glu490Asp polymorphism was associated with endurance athletic status and performance. Our findings suggest that, although ethnic differences may exist, the presence of the major T-allele (i.e., the Glu-490 allele) favours endurance performance more than the mutant A-allele (i.e., the 490-Asp allele).
Collapse
|
4
|
Ben-Zaken S, Meckel Y, Nemet D, Kassem E, Eliakim A. Genetic Basis for the Dominance of Israeli Long-Distance Runners of Ethiopian Origin. J Strength Cond Res 2021; 35:1885-1896. [PMID: 30741858 DOI: 10.1519/jsc.0000000000002989] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
ABSTRACT Ben-Zaken, S, Meckel, Y, Nemet, D, Kassem, E, and Eliakim, A. Genetic basis for the dominance of Israeli long-distance runners of Ethiopian origin. J Strength Cond Res 35(7): 1885-1896, 2021-Israeli long-distance runners of Ethiopian origin have a major influence on the track and field long-distance record table. The aim of this study was to determine whether genetic characteristics contribute to this long-distance dominance. We assessed polymorphisms in genes related to endurance (PPARD T/C), endurance trainability (ACSL A/G), speed (ACTN3 R/X), strength (AGT T/C), and the recovery from training (MTC1 A/T and IL6 G/C) among top Israeli long-distance runners of Ethiopian origin (n = 37), Israeli non-Ethiopian origin runners of Caucasian origin (n = 76), and Israeli nonathletic controls (n = 55). Israeli runners of Ethiopian origin had a greater frequency of the PPARD CC + PARGC1A Gly/Gly polymorphism, associated with improved endurance performance, compared with Israeli runners of non-Ethiopian origins (24 vs. 3%, respectively, p < 0.01); a lower frequency of the ACSL AA polymorphism, favoring endurance trainability (8 vs. 20%, respectively, p < 0.05); a greater frequency of the ACTN3 RR polymorphism, associated with sprint performance (35 vs. 20%, respectively, p < 0.05); a greater frequency of the MCT1 AA genotype, associated with improved lactate transport (65 vs. 45%, respectively, p < 0.05); and a lower frequency of IL-6 174C carriers, associated with reduced postexercise muscle damage (27 vs. 40%, respectively, p < 0.01). There was no difference in the frequency of AGT T/C gene polymorphism between the long-distance runners of Ethiopian and non-Ethiopian origin. Frequencies of PPARD CC + PARGC1A Gly/Gly, MCT1 AA, IL-6 174C, and AGT polymorphism were significantly favorable among Ethiopian, but not among non-Ethiopian, origin runners compared with controls. Taken together, results suggest that genetically, the dominance of Israeli long-distance runners of Ethiopian origin relates not only to endurance polymorphisms but also to polymorphisms associated with enhanced speed performance and better training recovery ability.
Collapse
Affiliation(s)
- Sigal Ben-Zaken
- Genetics and Molecular Biology Laboratory, The Zinman College of Physical Education and Sports Sciences at the Wingate Institute, Netanya, Israel
| | - Yoav Meckel
- Genetics and Molecular Biology Laboratory, The Zinman College of Physical Education and Sports Sciences at the Wingate Institute, Netanya, Israel
| | - Dan Nemet
- Pediatric Department, Meir Medical Center, Child Health and Sports Center, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel ; and
| | - Eias Kassem
- Pediatric Department, Hilel-Yaffe Medical Center, Hadera, Israel
| | - Alon Eliakim
- Pediatric Department, Meir Medical Center, Child Health and Sports Center, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel ; and
| |
Collapse
|
5
|
Corpas M, Megy K, Mistry V, Metastasio A, Lehmann E. Whole Genome Interpretation for a Family of Five. Front Genet 2021; 12:535123. [PMID: 33763108 PMCID: PMC7982663 DOI: 10.3389/fgene.2021.535123] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2020] [Accepted: 02/15/2021] [Indexed: 12/19/2022] Open
Abstract
Although best practices have emerged on how to analyse and interpret personal genomes, the utility of whole genome screening remains underdeveloped. A large amount of information can be gathered from various types of analyses via whole genome sequencing including pathogenicity screening, genetic risk scoring, fitness, nutrition, and pharmacogenomic analysis. We recognize different levels of confidence when assessing the validity of genetic markers and apply rigorous standards for evaluation of phenotype associations. We illustrate the application of this approach on a family of five. By applying analyses of whole genomes from different methodological perspectives, we are able to build a more comprehensive picture to assist decision making in preventative healthcare and well-being management. Our interpretation and reporting outputs provide input for a clinician to develop a healthcare plan for the individual, based on genetic and other healthcare data.
Collapse
Affiliation(s)
- Manuel Corpas
- Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, Cambridge, United Kingdom.,Institute of Continuing Education Madingley Hall Madingley, University of Cambridge, Cambridge, United Kingdom.,Facultad de Ciencias de la Salud, Universidad Internacional de La Rioja, Madrid, Spain
| | - Karyn Megy
- Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, Cambridge, United Kingdom.,Department of Haematology, University of Cambridge & National Health Service (NHS) Blood and Transplant, Cambridge, United Kingdom
| | | | - Antonio Metastasio
- Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, Cambridge, United Kingdom.,Camden and Islington NHS Foundation Trust, London, United Kingdom
| | - Edmund Lehmann
- Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, Cambridge, United Kingdom
| |
Collapse
|
6
|
Ropka-Molik K, Stefaniuk-Szmukier M, Szmatoła T, Piórkowska K, Bugno-Poniewierska M. The use of the SLC16A1 gene as a potential marker to predict race performance in Arabian horses. BMC Genet 2019; 20:73. [PMID: 31510920 PMCID: PMC6740031 DOI: 10.1186/s12863-019-0774-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Accepted: 08/29/2019] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Arabian horses are commonly believed to be one of the oldest and the most popular horse breeds in the world, characterized by favourable stamina traits and exercise phenotypes. During intensive training, the rates of lactate production and utilization are critical to avoid muscle fatigue and a decrease in exercise performance. The key factor determining transmembrane lactate transport is the monocarboxylate transporter 1 protein coded for by the SLC16A1 gene. The aim of the present research was to identify polymorphisms in the coding sequence and UTRs in the equine SLC16A1 gene and to evaluate their potential association with race performance traits in Arabian horses. Based on RNA-seq data, SNPs were identified and genotyped using PCR-RFLP or PCR-HRM methods in 254 Arabian horses that competed in flat races. An association analysis between polymorphisms and racing results was performed. RESULTS Novel polymorphisms in the equine SLC16A1 locus have been identified (missense and 5'UTR variants: g.55601543C > T and g.55589063 T > G). Analysis showed a significant association between the 5'UTR polymorphism and several racing results as follows: the possibility of winning first or second place, the number of races in which horses started and total financial benefits. The analysis also showed differences in genotype distribution depending on race distance. In the studied population, the shorter distance races were only won by TT horses. The GG and TG horses took first and second places in middle- and long-distance races, and the percentage of winning heterozygotes increased from 19.5 to 27% at the middle and long distances, respectively. The p.Val432Ile (g.55601543C > T) polymorphism was not significantly related to the analysed racing results. CONCLUSION Our results showed that g.55589063 T > G polymorphism affected the possibility of winning first or second place and of competing in more races. The different distribution of genotypes depending on race distance indicated the possibility of using a SNP in the SLC16A1 gene as a marker to predict the best race distance for a horse. The presented results provide a basis for further research to validate the use of the SLC16A1 gene as a potential marker associated with racing performance.
Collapse
Affiliation(s)
- Katarzyna Ropka-Molik
- Department of Animal Molecular Biology, Laboratory of Genomics, National Research Institute of Animal Production, Krakowska 1,, 32-083, Balice, Poland.
| | - Monika Stefaniuk-Szmukier
- Department of Horse Breeding, Institute of Animal Science, University of Agriculture in Cracow, Cracow, Poland
| | - Tomasz Szmatoła
- Department of Animal Molecular Biology, Laboratory of Genomics, National Research Institute of Animal Production, Krakowska 1,, 32-083, Balice, Poland.,University Centre of Veterinary Medicine, University of Agriculture in Cracow, Mickiewicza 24/28, 30-059, Cracow, Poland
| | - Katarzyna Piórkowska
- Department of Animal Molecular Biology, Laboratory of Genomics, National Research Institute of Animal Production, Krakowska 1,, 32-083, Balice, Poland
| | - Monika Bugno-Poniewierska
- Department of Animal Molecular Biology, Laboratory of Genomics, National Research Institute of Animal Production, Krakowska 1,, 32-083, Balice, Poland.,Department of Animals Reproduction, Anatomy and Genomics, University of Agriculture in Cracow, Cracow, Poland
| |
Collapse
|
7
|
Lopes-Silva JP, Choo HC, Franchini E, Abbiss CR. Isolated ingestion of caffeine and sodium bicarbonate on repeated sprint performance: A systematic review and meta-analysis. J Sci Med Sport 2019; 22:962-972. [PMID: 31036532 DOI: 10.1016/j.jsams.2019.03.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2018] [Revised: 03/11/2019] [Accepted: 03/14/2019] [Indexed: 01/27/2023]
Abstract
OBJECTIVES This study is a systematic review and meta-analysis aimed at investigating the isolated effects of caffeine and sodium bicarbonate (NaHCO3) ingestion on repeated sprint ability (RSA). METHODS Following a search through PubMed and Scopus, 13 studies (7 with caffeine and 6 with NaHCO3) were found to meet inclusion criteria. Random-effects of standardized mean difference (SMD) for total work and best sprint performance was examined. Study quality was assessed using QualSyst. RESULTS The meta-analysis indicated that caffeine ingestion did not improve the total work done (weighted average effect size Hedges's g = -0.01, 95%CI: -0.32 to 0.31, p = 0.97), best sprint (weighted average effect size Hedges's g = -0.02, 95% CI: -0.32 to 0.27; p = 0.87) or last sprint performance (weighed average effect size Hedge's g = -0.27, 95%CI: -0.68 to 0.14; p = 0.20), when compared with a placebo condition. Similarly, NaHCO3 ingestion did not improve the total work done (weighted average effect size Hedges's g = 0.43, 95% CI: -0.11 to 0.97, p = 0.12), best sprint (weighted average effect size Hedges's g = 0.02, 95% CI -0.30 to 0.34; p = 0.90) or last sprint performance (weighted average effect size Hedge's g = 0.20, 95%CI: -0.13 to 0.52, p = 0.14), compared with a placebo condition. Quality assessment of selected articles was classified as strong. CONCLUSION This meta-analysis provides evidence that repeated sprint ability is not affected by acute ingestion of caffeine or NaHCO3.
Collapse
Affiliation(s)
- João P Lopes-Silva
- School of Physical Education, Cesmac University Center, Maceió, Alagoas, Brazil; UNINASSAU, Maceió, Alagoas, Brazil; High-Intensity Intermittent Exercise Physiology Research Group, School of Physical and Education and Sport, University of São Paulo, São Paulo, Brazil.
| | - Hui C Choo
- Centre for Exercise and Sports Science Research (CESSR), School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Dr, Joondalup, WA 6027, Australia
| | - Emerson Franchini
- High-Intensity Intermittent Exercise Physiology Research Group, School of Physical and Education and Sport, University of São Paulo, São Paulo, Brazil; Australian Institute of Sport, Canberra, Australia
| | - Chris R Abbiss
- Centre for Exercise and Sports Science Research (CESSR), School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Dr, Joondalup, WA 6027, Australia
| |
Collapse
|
8
|
Heibel AB, Perim PHL, Oliveira LF, McNaughton LR, Saunders B. Time to Optimize Supplementation: Modifying Factors Influencing the Individual Responses to Extracellular Buffering Agents. Front Nutr 2018; 5:35. [PMID: 29868599 PMCID: PMC5951986 DOI: 10.3389/fnut.2018.00035] [Citation(s) in RCA: 57] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2018] [Accepted: 04/19/2018] [Indexed: 11/13/2022] Open
Abstract
Blood alkalosis, as indicated by an increased blood bicarbonate concentration and pH, has been shown to be beneficial for exercise performance. Sodium bicarbonate, sodium citrate, and sodium or calcium lactate, can all result in increased circulating bicarbonate and have all independently been shown to improve exercise capacity and performance under various circumstances. Although there is considerable evidence demonstrating the efficacy of these supplements in several sports-specific situations, it is commonly acknowledged that their efficacy is equivocal, due to contrasting evidence. Herein, we discuss the physiological and environmental factors that may modify the effectiveness of these supplements including, (i) absolute changes in circulating bicarbonate; (ii) supplement timing, (iii) the exercise task performed, (iv) monocarboxylate transporter (MCT) activity; (v) training status, and (vi) associated side-effects. The aim of this narrative review is to highlight the factors which may modify the response to these supplements, so that individuals can use this information to attempt to optimize supplementation and allow the greatest possibility of an ergogenic effect.
Collapse
Affiliation(s)
- André B Heibel
- Applied Physiology and Nutrition Research Group, University of São Paulo, São Paulo, Brazil.,Laboratory of Nutritional Biochemistry, University of Brasília, Brasília, Brazil
| | - Pedro H L Perim
- Applied Physiology and Nutrition Research Group, University of São Paulo, São Paulo, Brazil.,São Camilo University Centre, São Paulo, Brazil
| | - Luana F Oliveira
- Applied Physiology and Nutrition Research Group, University of São Paulo, São Paulo, Brazil.,School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil
| | - Lars R McNaughton
- Sports Nutrition and Performance Group, Department of Sport and Physical Activity, Edge Hill University, Ormskirk, United Kingdom.,Department of Sport and Movement Studies, Faculty of Health Science, University of Johannesburg, Johannesburg, South Africa
| | - Bryan Saunders
- Applied Physiology and Nutrition Research Group, University of São Paulo, São Paulo, Brazil.,Rheumatology Division, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.,Institute of Orthopaedics and Traumatology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
9
|
Nine genetic polymorphisms associated with power athlete status - A Meta-Analysis. J Sci Med Sport 2017; 21:213-220. [PMID: 28666769 DOI: 10.1016/j.jsams.2017.06.012] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2016] [Revised: 06/04/2017] [Accepted: 06/13/2017] [Indexed: 01/22/2023]
Abstract
OBJECTIVES In this study the association between genetic polymorphisms and power athlete status with possible interference by race and sex was investigated to identify genetic variants favourable for becoming a power athlete. DESIGN This meta-analysis included both, case-control and Cohort studies. METHODS Databases of PubMed and Web of Science were searched for studies reporting on genetic polymorphisms associated with the status of being a power athlete. Thirty-five articles published between 2008 and 2016 were identified as eligible including a total number of 5834 power athletes and 14,018 controls. A series of meta-analyses were conducted for each of the identified genetic polymorphisms associated with power athlete status. Odds ratios (ORs) based on the allele and genotype frequency with corresponding 95% confidence intervals (95%CI) were calculated per genetic variant. Heterogeneity of the studies was addressed by Chi-square based Q-statistics at 5% significance level and a fixed or random effects model was used in absence or presence of heterogeneity respectively. Stratified analyses were conducted by race and sex to explore potential sources of heterogeneity. RESULTS Significant associations were found for the genetic polymorphisms in the ACE (rs4363, rs1799752), ACTN3 (rs1815739), AGT (rs699), IL6-174 (rs1800795), MnSOD (rs1799725), NOS3 (rs1799983, rs2070744) and SOD2 (rs4880) genes. CONCLUSIONS Nine genetic polymorphisms have been identified in the meta-analyses to have a significant association with the status of being a power athlete. Nevertheless, more research on the investigated genes needs to be done to draw comprehensive conclusions.
Collapse
|
10
|
Massidda M, Eynon N, Bachis V, Corrias L, Culigioni C, Cugia P, Scorcu M, Calò CM. Association Between MCT1 A1470T Polymorphism and Fat-Free Mass in Well-Trained Young Soccer Players. J Strength Cond Res 2016; 30:1171-6. [PMID: 26340466 DOI: 10.1519/jsc.0000000000001176] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The aim of this study was to investigate the association between the MCT1 A1470T polymorphism and fat-free mass in young Italian elite soccer players. Participants were 128 Italian male soccer players. Fat-free mass was estimated for each of the soccer player using age- and gender-specific formulas with plicometry. Genotyping for the MCT1 A1470T polymorphism was performed using polymerase chain reaction. The MCT1 A1470T genotypes were in agreement with the Hardy-Weinberg equilibrium distribution. The percentage of fat-free mass was significantly higher in soccer players with the TT genotype and in the T-allele-dominant model group (TT + AT) compared with the soccer players with the AA genotype. The MCT1 T allele is associated with the percentage of fat-free mass in young elite male soccer players. Elucidating the genetic basis of body composition in athletes could potentially be used as an additional tool for strength and conditioning professionals in planning and adjusting training. However, these results are preliminary and need to be replicated in more cohorts.
Collapse
Affiliation(s)
- Myosotis Massidda
- 1Department Life and Environmental Sciences, Cagliari University, Cagliari, Italy; 2Institute of Sport, Exercise and Active Living (ISEAL), Victoria University, Victoria, Australia; and 3FMSI CR Sardegna and Cagliari Calcio Spa, Cagliari, Italy
| | | | | | | | | | | | | | | |
Collapse
|
11
|
González-Haro C, Soria M, Vicente J, Fanlo AJ, Sinués B, Escanero JF. Variants of the Solute Carrier SLC16A1 Gene (MCT1) Associated With Metabolic Responses During a Long-Graded Test in Road Cyclists. J Strength Cond Res 2016; 29:3494-505. [PMID: 26595136 DOI: 10.1519/jsc.0000000000000994] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Variants of the solute carrier SLC16A1 gene have been associated with alterations in MCT1 expression, because of a lactate (La) transport deficiency across the cell membrane and a blood La accumulation. The aim of this study was to associate the allelic and genotypic frequencies of 1470T>A, 2917(1414) C>T, and IVS3-17A>C variants relative to the blood La kinetics and metabolic responses to a progressive effort until exhaustion. Twenty-five well-trained road cyclists performed a long-graded laboratory test: 10 minutes at 2.0 W·kg, first step at 2.5 W·kg with increments of 0.5 W·kg every 10 minutes until exhaustion. Blood La, nonesterified fatty acids (NEFAS), and glucose levels were measured; fat and carbohydrate oxidation rates were estimated through stoichiometric equations. Three variants of SLC16A1 gene were determined for each subject, which were divided in two groups: wt (wild type)/mt (mutated type) and mt/mt genotype group versus wt/wt genotype group. Metabolic responses were compared between both groups with an unpaired Student's t-test; Friedman and Wilcoxon tests were performed for nonparametric data. The statistical significance was set at p ≤ 0.05. For 1470TA polymorphism, no significant blood La differences were found between groups. 2197(1414)C>T allele carriers and IVS3-17A>C carriers showed significantly higher blood La levels, lower blood NEFAS, and glucose levels at submaximal intensities. These findings open a new perspective to investigate SLC16A1 variants (1470TA and IVS3-17A>C) on La deficiency transport and its regulation/interaction with other metabolic pathways. Future studies would be needed to clarify whether 1470T>A, 2917(1414)C>T, and IVS3-17A>C allelic/genotypic distribution benefit performance in endurance athletes.
Collapse
Affiliation(s)
- Carlos González-Haro
- Department Pharmacology and Physiology, School of Medicine, University of Zaragoza, Zaragoza, Spain
| | | | | | | | | | | |
Collapse
|
12
|
Cupeiro R, Pérez-Prieto R, Amigo T, Gortázar P, Redondo C, González-Lamuño D. Role of the monocarboxylate transporter MCT1 in the uptake of lactate during active recovery. Eur J Appl Physiol 2016; 116:1005-10. [PMID: 27026015 DOI: 10.1007/s00421-016-3365-3] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2015] [Accepted: 03/12/2016] [Indexed: 11/28/2022]
Abstract
PURPOSE We assessed the role of monocarboxylate transporter 1 (MCT1) on lactate clearance during an active recovery after high-intensity exercise, by comparing genetic groups based on the T1470A (rs1049434) MCT1 polymorphism, whose influence on lactate transport has been proven. METHODS Sixteen young male elite field hockey players participated in this study. All of them completed two 400 m maximal run tests performed on different days, followed by 40 min of active or passive recovery. Lactate samples were measured immediately after the tests, and at min 10, 20, 30 and 40 of the recoveries. Blood lactate decreases were calculated for each 10-min period. Participants were distributed into three groups according to the T1470A polymorphism (TT, TA and AA). RESULTS TT group had a lower blood lactate decrease than AA group during the 10-20 min period of the active recovery (p = 0.018). This period had the highest blood lactate for the whole sample, significantly differing from the other periods (p ≤ 0.003). During the passive recovery, lactate declines were constant except for the 0-10-min period (p ≤ 0.003), suggesting that liver uptake is similar in all the genetic groups, and that the difference seen during the active recovery is mainly due to muscle lactate uptake. CONCLUSIONS These differences according to the polymorphic variant T1470A suggest that MCT1 affects the plasma lactate decrease during a crucial period of active recovery, where the maximal lactate amount is cleared (i.e. 10-20 min period).
Collapse
Affiliation(s)
- Rocío Cupeiro
- LFE Research Group, Faculty of Physical Activity and Sports Sciences-INEF, Universidad Politécnica de Madrid, C/Martín Fierro no 7, 28040, Madrid, Spain.
| | - Raúl Pérez-Prieto
- Laboratory of Pediatrics, Facultad de Medicina, Universidad de Cantabria, Avda. Cardenal Herrera Oria s/n, 39011, Santander, Cantabria, Spain
| | - Teresa Amigo
- Laboratory of Pediatrics, Facultad de Medicina, Universidad de Cantabria, Avda. Cardenal Herrera Oria s/n, 39011, Santander, Cantabria, Spain.,Division of Pediatrics, Valdecilla Research Institute (IDIVAL), Edificio IDIVAL, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Cantabria, Spain
| | - Pilar Gortázar
- Division of Pediatrics, Valdecilla Research Institute (IDIVAL), Edificio IDIVAL, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Cantabria, Spain
| | - Carlos Redondo
- Laboratory of Pediatrics, Facultad de Medicina, Universidad de Cantabria, Avda. Cardenal Herrera Oria s/n, 39011, Santander, Cantabria, Spain
| | - Domingo González-Lamuño
- Laboratory of Pediatrics, Facultad de Medicina, Universidad de Cantabria, Avda. Cardenal Herrera Oria s/n, 39011, Santander, Cantabria, Spain.,Division of Pediatrics, Valdecilla Research Institute (IDIVAL), Edificio IDIVAL, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Cantabria, Spain
| |
Collapse
|
13
|
Sasaki S, Futagi Y, Kobayashi M, Ogura J, Iseki K. Functional characterization of 5-oxoproline transport via SLC16A1/MCT1. J Biol Chem 2014; 290:2303-11. [PMID: 25371203 DOI: 10.1074/jbc.m114.581892] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Thyrotropin-releasing hormone is a tripeptide that consists of 5-oxoproline, histidine, and proline. The peptide is rapidly metabolized by various enzymes. 5-Oxoproline is produced by enzymatic hydrolysis in a variety of peptides. Previous studies showed that 5-oxoproline could become a possible biomarker for autism spectrum disorders. Here we demonstrate the involvement of SLC16A1 in the transport of 5-oxoproline. An SLC16A1 polymorphism (rs1049434) was recently identified. However, there is no information about the effect of the polymorphism on SLC16A1 function. In this study, the polymorphism caused an observable change in 5-oxoproline and lactate transport via SLC16A1. The Michaelis constant (Km) was increased in an SLC16A1 mutant compared with that in the wild type. In addition, the proton concentration required to produce half-maximal activation of transport activity (K0.5, H (+)) was increased in the SLC16A1 mutant compared with that in the wild type. Furthermore, we examined the transport of 5-oxoproline in T98G cells as an astrocyte cell model. Despite the fact that 5-oxoproline is an amino acid derivative, Na(+)-dependent and amino acid transport systems scarcely contributed to 5-oxoproline transport. Based on our findings, we conclude that H(+)-coupled 5-oxoproline transport is mediated solely by SLC16A1 in the cells.
Collapse
Affiliation(s)
- Shotaro Sasaki
- From the Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812 and
| | - Yuya Futagi
- From the Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812 and
| | - Masaki Kobayashi
- From the Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812 and
| | - Jiro Ogura
- From the Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812 and
| | - Ken Iseki
- From the Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812 and the Department of Pharmacy, Hokkaido University Hospital, Sapporo 060-8648, Japan
| |
Collapse
|